November 18, 2025

Impact of beta-blockers on long-term mortality in Takotsubo syndrome: a real-world analysis of the TriNetX Global Collaborative Network database

HJHritvik JainInterventional Cardiology KSKriti SoniSUNY Upstate Medical University RORamez M. OdatJordan University of Science and Technology

Structured PICO

Does beta-blocker use reduce short- and long-term mortality in patients with Takotsubo syndrome?

Population

Patients with Takotsubo syndrome (TTS)

Intervention

Beta-blockers

Outcome

Short- and long-term mortalityhard clinical

Real-world data suggests beta-blocker use is associated with improved short- and long-term survival up to 5 years in patients with Takotsubo syndrome.

Abstract

Beta blocker use in patients with TTS was associated with a lower risk of short- and long-term mortality up to 5 years.

KI fragen

Bookmark

View Full Paper

Cite This Study

Jain et al. (Tue,) studied this question.

synapsesocial.com/papers/69cdfe623d84e1f5ff46c47a https://doi.org/https://doi.org/10.1093/ehjacc/zuaf154

KI fragen

Bookmark

View Full Paper